L01XG Proteasome inhibitors, antineoplastic agent
ATC class of level 4 – chemical subgroup
This page lists the patient medication information or the product monograph for 19 drugs in this drug class and its subclasses.
- 19 prescription (Rx)
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,069 drugs
- L01 Antineoplastic agents 616 drugs
- L01X Other antineoplastic agents 120 drugs
-
L01XG Proteasome inhibitors, antineoplastic agent 19 drugs
- L01XG01 Bortezomib 17 drugs
- L01XG02 Carfilzomib 1 drug
- L01XG03 Ixazomib 1 drug
-
L01XG Proteasome inhibitors, antineoplastic agent 19 drugs
- L01X Other antineoplastic agents 120 drugs
- L01 Antineoplastic agents 616 drugs
Active ingredients of the class
- Bortezomib 1 drug
- Bortezomib (bortezomib mannitol boronic ester) 16 drugs
- Carfilzomib 1 drug
- Ixazomib (ixazomib citrate) 1 drug
Drugs in the class and its subclasses
Other classes of the same level
- L01XA Platinum compounds, antineoplastic drugs 37 drugs
- L01XB Methylhydrazines, antineoplastics 1 drug
- L01XD Sensitizers used in photodynamic/radiation therapy 4 drugs
- L01XF Retinoids for cancer treatment 2 drugs
- L01XH Histone deacetylase (HDAC) inhibitors 2 drugs
- L01XJ Hedgehog pathway inhibitors 3 drugs
- L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors 5 drugs
- L01XX Other antineoplastic agents 36 drugs
- L01XY Combinations of antineoplastic agents 1 drug
Other names of the drug class
- English (United Kingdom): L01XG Proteasome inhibitors, antineoplastic agent
- German: L01XG Proteasom-Inhibitoren
- German (Austria): L01XG Proteasom-Inhibitoren
- Italian: L01XG Ibibitori dei proteasomi
- Turkish: L01XG Proteazom inhibitörleri, antineoplastik ajan
- Czech: L01XG Inhibitory proteazomu
- Slovak: L01XG Inhibítory proteazómu
- German (Switzerland): L01XG Proteasom-Inhibitoren
- Italian (Switzerland): L01XG Ibibitori dei proteasomi
- Dutch: L01XG Proteasoomremmers, oncolytica
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L01XG
Ask your doctor or pharmacist for advice.